Literature DB >> 19576918

PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium.

Xuhui Zhu1, Honghong Yao, Fuwang Peng, Shannon Callen, Shilpa Buch.   

Abstract

The human immunodeficiency virus (HIV-1) protein Tat has been implicated in mediating neuronal apoptosis, one of the hallmark features of HIV-associated dementia (HAD). Mitigation of the toxic effects of Tat could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study we demonstrated that Tat-induced neurotoxicity was abolished by NMDA antagonist-MK801, suggesting the role of glutamate in this process. Furthermore, we also found that pretreatment of SH-SY5Y cells with PDGF exerted protection against Tat toxicity by decreasing extracellular glutamate levels. We also demonstrated that extracellular calcium chelator EGTA was able to abolish PDGF-mediated neuroprotection, thereby underscoring the role of calcium signaling in PDGF-mediated neuroprotection. We also showed that Erk signaling pathway was critical for PDGF-mediated protection of cells. Additionally, blocking calcium entry with EGTA resulted in suppression of PDGF-induced Erk activation. These findings thus underscore the role of PDGF-mediated calcium signaling and Erk phosphorylation in the protection of cells against HIV Tat toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576918      PMCID: PMC2753679          DOI: 10.1016/j.taap.2009.06.020

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  41 in total

1.  HIV and HIV dementia.

Authors:  D L Kolson; F González-Scarano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons.

Authors:  R Bonavia; A Bajetto; S Barbero; A Albini; D M Noonan; G Schettini
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

3.  Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Authors:  Y Liu; M Jones; C M Hingtgen; G Bu; N Laribee; R E Tanzi; R D Moir; A Nath; J J He
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

4.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

Review 5.  Pathogenesis of human immunodeficiency virus-induced neurological disease.

Authors:  Andrew V Albright; Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 6.  The neuropathogenesis of HIV-1 infection.

Authors:  H E Gendelman; S A Lipton; M Tardieu; M I Bukrinsky; H S Nottet
Journal:  J Leukoc Biol       Date:  1994-09       Impact factor: 4.962

7.  Neurotrophic activity of platelet-derived growth factor (PDGF): Rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF.

Authors:  A Smits; M Kato; B Westermark; M Nistér; C H Heldin; K Funa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Lithium ameliorates HIV-gp120-mediated neurotoxicity.

Authors:  Ian P Everall; Christopher Bell; Margaret Mallory; Dianne Langford; Anthony Adame; Edward Rockestein; Eliezer Masliah
Journal:  Mol Cell Neurosci       Date:  2002-11       Impact factor: 4.314

9.  MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis.

Authors:  E A Eugenin; T G D'Aversa; L Lopez; T M Calderon; J W Berman
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

Review 10.  Characterization and expression of novel 60-kDa and 110-kDa EGFR isoforms in human placenta.

Authors:  Jill L Reiter; Nita J Maihle
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

View more
  15 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

Review 2.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

3.  Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.

Authors:  Liang Hui; Xuesong Chen; Dhaval Bhatt; Nicholas H Geiger; Thad A Rosenberger; Norman J Haughey; Susan A Masino; Jonathan D Geiger
Journal:  J Neurochem       Date:  2012-05-17       Impact factor: 5.372

4.  PDGF-BB protects mitochondria from rotenone in T98G cells.

Authors:  Ricardo Cabezas; Marcos Fidel Avila; Janneth González; Ramon Santos El-Bachá; George E Barreto
Journal:  Neurotox Res       Date:  2014-12-17       Impact factor: 3.911

5.  Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.

Authors:  Patrick R Stevens; Jeremy W Gawryluk; Liang Hui; Xuesong Chen; Jonathan D Geiger
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

7.  Mechanisms of Platelet-Derived Growth Factor-BB in Restoring HIV Tat-Cocaine-Mediated Impairment of Neuronal Differentiation.

Authors:  Lu Yang; Xufeng Chen; Guoku Hu; Yu Cai; Ke Liao; S Buch
Journal:  Mol Neurobiol       Date:  2015-11-17       Impact factor: 5.590

8.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

Review 9.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

10.  Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.

Authors:  Jason J Paris; Jason Fenwick; Jay P McLaughlin
Journal:  Horm Behav       Date:  2014-04-12       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.